Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis
October 3, 2022
Beyond Air® To Participate in Three Upcoming Investor Conferences
September 16, 2022
Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)
August 23, 2022
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023
August 11, 2022
Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast
July 27, 2022
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022
June 28, 2022
Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
June 28, 2022
Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th
June 14, 2022
Beyond Cancer™ Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer
June 1, 2022
Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022
May 17, 2022

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe